MedPath

Cardiovascular Risk in Toledo Population

Conditions
Cardiovascular Risk Factor
Cardiovascular Diseases
Registration Number
NCT03294369
Lead Sponsor
Castilla-La Mancha Health Service
Brief Summary

This epidemiological and observational study is aimed to assess cardiovascular risk (CVR) by investigating the prevalence of CVR factors (CVRF), target organ damage (TOD) and cardiovascular disease (CVD) in general population of the sanitary area of Toledo.

Detailed Description

Epidemiological and observational study that is analyzing a sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.

Clinical history, physical examination and complementary tests are being performed.

Total blood and serum samples are being frozen (-85ºC) for future genetic studies. The biobank is currently being registered at the "Virgen de la Salud" hospital of Toledo.

CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.

Patients will be periodically visited, with a minimum follow-up of 5 years. Standard statistical analysis will be performed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3125
Inclusion Criteria
  • Subjects aged 18 years or older, randomly selected from a database of health cards stratified by age and gender
Exclusion Criteria
  • Individulas aged under 18 years.
  • Subjects who do not sign the informed consent.
  • Subjects that due to different conditions (physical, mental or social) is expected that do not complete the expected follow-up.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of cardiovascular diseaseDecember 2020

To assess the prevalence of cardiovascular disease

Assess cardiovascular risk of the study populationDecember 2020

Cardiovascular risk will be determined according to SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.

Prevalence of cardiovascular risk factorsDecember 2020

To assess the prevalence of cardiovascular risk factors

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Avenida de Irlanda, 12, 2º A

🇪🇸

Toledo, Spain

Avenida de Irlanda, 12, 2º A
🇪🇸Toledo, Spain
Gustavo C Rodriguez-Roca, MD, PhD
Contact
608293478
gcrodriguezroca@gmail.com
Francisco J Alonso-Moreno, MD, PhD
Sub Investigator
Alejandro Villarin-Castro, MD
Sub Investigator
Antonio Segura-Fragoso, MD, PhD
Sub Investigator
Luis Rodriguez-Padial, MD, PhD
Sub Investigator
Juan Fernandez-Martin, MD, PhD
Sub Investigator
Carlos Escobar-Cervantes, MD, PhD
Sub Investigator
© Copyright 2025. All Rights Reserved by MedPath